BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 29876690)

  • 1. Differences in clinical Pneumocystis pneumonia in rheumatoid arthritis and other connective tissue diseases suggesting a rheumatoid-specific interstitial lung injury spectrum.
    Shimada K; Yokosuka K; Nunokawa T; Sugii S
    Clin Rheumatol; 2018 Aug; 37(8):2269-2274. PubMed ID: 29876690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and radiological features of Pneumocystis pneumonia in patients with rheumatoid arthritis, in comparison with methotrexate pneumonitis and Pneumocystis pneumonia in acquired immunodeficiency syndrome: a multicenter study.
    Tokuda H; Sakai F; Yamada H; Johkoh T; Imamura A; Dohi M; Hirakata M; Yamada T; Kamatani N; Kikuchi Y; Sugii S; Takeuchi T; Tateda K; Goto H
    Intern Med; 2008; 47(10):915-23. PubMed ID: 18480575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute exacerbation of interstitial pneumonia associated with rheumatoid arthritis during the course of treatment for Pneumocystis jirovecii pneumonia: a case report.
    Kuroda T; Takeuchi H; Nozawa Y; Sato H; Nakatsue T; Wada Y; Moriyama H; Nakano M; Narita I
    BMC Res Notes; 2016 Apr; 9():240. PubMed ID: 27113212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents: importance of Pneumocystis pneumonia in Japan revealed by a multicenter study.
    Kameda H; Tokuda H; Sakai F; Johkoh T; Mori S; Yoshida Y; Takayanagi N; Taki H; Hasegawa Y; Hatta K; Yamanaka H; Dohi M; Hashimoto S; Yamada H; Kawai S; Takeuchi T; Tateda K; Goto H
    Intern Med; 2011; 50(4):305-13. PubMed ID: 21325762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of pneumocystis pneumonia complicated in patients with rheumatoid arthritis (RA) and non-RA rheumatic diseases.
    Yoshida Y; Takahashi Y; Minemura N; Ueda Y; Yamashita H; Kaneko H; Mimori A
    Mod Rheumatol; 2012 Aug; 22(4):509-14. PubMed ID: 21971942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pneumocystis pneumonia developed in two patients with rheumatoid arthritis during treatment of adalimumab].
    Ikeuchi H; Umemoto A; Tsukida M; Sakurai N; Maeshima A; Kuroiwa T; Hiromura K; Nojima Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(5):420-5. PubMed ID: 22041430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes and risk factors for mortality in Pneumocystis pneumonia patients with rheumatoid arthritis: A multicentre retrospective cohort study.
    Mori S; Ueki Y; Miyamura T; Ishii K; Hidaka T; Yoshitama T; Nakamura K; Suenaga Y
    Mod Rheumatol; 2023 Jul; 33(4):723-731. PubMed ID: 35920411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Soluble Interleukin-2 Receptor Is a Biomarker for Pneumocystis jirovecii Pneumonia among Patients with Rheumatoid Arthritis under Methotrexate Therapy.
    Sakamoto N; Hara S; Ishimoto H; Nakashima S; Yura H; Miyamura T; Okuno D; Hara A; Kakugawa T; Yamaguchi H; Obase Y; Kushima H; Ishii H; Noguchi S; Kido T; Kobayashi T; Soejima Y; Yoshioka S; Ishimatsu Y; Yatera K; Kadota JI; Mukae H
    Tohoku J Exp Med; 2019 Jul; 248(3):209-216. PubMed ID: 31366819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Pneumocystis pneumonia infection risk factors in patients with connective tissue disease.
    Iikuni N; Kitahama M; Ohta S; Okamoto H; Kamatani N; Nishinarita M
    Mod Rheumatol; 2006; 16(5):282-8. PubMed ID: 17039308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated with Pneumocystis jirovecii Pneumonia in Patients with Rheumatoid Arthritis Receiving Methotrexate: A Single-center Retrospective Study.
    Ohmura SI; Homma Y; Masui T; Miyamoto T
    Intern Med; 2022 Apr; 61(7):997-1006. PubMed ID: 34511571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy.
    Mori S; Cho I; Ichiyasu H; Sugimoto M
    Mod Rheumatol; 2008; 18(3):240-6. PubMed ID: 18306977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A followup study of asymptomatic carriers of Pneumocystis jiroveci during immunosuppressive therapy for rheumatoid arthritis.
    Mori S; Cho I; Sugimoto M
    J Rheumatol; 2009 Aug; 36(8):1600-5. PubMed ID: 19531759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for malignant rheumatoid arthritis].
    Okuda Y; Oyama T; Oyama H; Miyamoto T; Takasugi K
    Ryumachi; 1995 Aug; 35(4):699-704. PubMed ID: 7482069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pneumocystis jiroveci pneumonia as a complication of glucocorticoid therapy for interstitial pneumonia].
    Enomoto T; Azuma A; Matsumoto A; Nei T; Hiramatsu K; Abe S; Usuki J; Kudoh S
    Nihon Kokyuki Gakkai Zasshi; 2005 Dec; 43(12):725-30. PubMed ID: 16457333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality.
    Ward MM; Donald F
    Arthritis Rheum; 1999 Apr; 42(4):780-9. PubMed ID: 10211894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case-control study of 17 patients.
    Watanabe K; Sakai R; Koike R; Sakai F; Sugiyama H; Tanaka M; Komano Y; Akiyama Y; Mimura T; Kaneko M; Tokuda H; Iso T; Motegi M; Ikeda K; Nakajima H; Taki H; Kubota T; Kodama H; Sugii S; Kuroiwa T; Nawata Y; Shiozawa K; Ogata A; Sawada S; Matsukawa Y; Okazaki T; Mukai M; Iwahashi M; Saito K; Tanaka Y; Nanki T; Miyasaka N; Harigai M
    Mod Rheumatol; 2013 Nov; 23(6):1085-93. PubMed ID: 23212592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of pneumocystis pneumonia in patients with rheumatoid arthritis].
    Miyahara Y; Takayanagi N; Ishiguro T; Yoneda K; Tokunaga D; Aoki F; Kurashima K; Yanagisawa T; Sugita Y
    Nihon Kokyuki Gakkai Zasshi; 2011 Jan; 49(1):3-9. PubMed ID: 21384675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts.
    Kiely P; Busby AD; Nikiphorou E; Sullivan K; Walsh DA; Creamer P; Dixey J; Young A
    BMJ Open; 2019 May; 9(5):e028466. PubMed ID: 31061059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Clinical Characteristics of Pneumocystis Pneumonia between Patients with Rheumatoid Arthritis Being Treated with Biologics and Those Being Treated without Biologics.
    Akiyama M; Kaneko Y; Takeuchi T
    Biomed Res Int; 2017; 2017():3710652. PubMed ID: 28785579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumocystis carinii pneumonia in patients with connective tissue disease.
    Li J; Huang XM; Fang WG; Zeng XJ
    J Clin Rheumatol; 2006 Jun; 12(3):114-7. PubMed ID: 16755237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.